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induce immune tolerance may also be required to mini-
mize rejection.Figure 1. Recovery of T cell subsets after matched and mismatched ASCT353
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Allogeneic stem-cell transplantation (ASCT) is curative for
many malignant and nonmalignant hematological disorders.
We aimed to study reconstitution of lymphocyte subsets
after matched and mismatched transplantation.
Lymphocyte subsets were evaluated by ﬂow cytometry at
1,3,6 and 12 months (mo) post-ASCT. Lymphocyte recovery
was determined using means at each time point and group
differences assessed using analysis of variance.Time-to-
event outcome were estimated by Kaplan-Meier survival
curves and the log-rank test was used to evaluate differences
between groups. 100 patients (pts) were included in the
study: 25 received a matched sibling (MSD), 20 pts
a matched unrelated donor ASCT 10/10 (MUD), 18 pts a 9/10
MUD, 9 pts a T cell depleted haploidentical (TCD haplo), and
28 a T cell replete haploidentical transplant (TCR haplo). 53
pts received bone marrow and 47 peripheral blood stem
cells. Most patients were treated for acute leukemia (AML 41,
ALL 23), 16 MDS, 6 CML, 4 CLL, 5 lymphoma. Median age was
43 years (range: 20-71). Median follow-up was 13.6 mo. 60
pts were alive and disease-free at last follow-up and 28 pts
died 75% of relapse. Non-relapse mortality (NRM) was 6% for
the entire cohort.
Overall, alive pts (vs. who died) had higher mean CD3
(615 vs. 349, P ¼ .03 on day 90), CD8 (427 vs. 187, P ¼ .03 on
day 90), CD4 (391 vs. 54, P¼ .01, on day 365), and lowermean
CD56 cells (178 vs 300, P¼ .01, on day 30) post ASCT. Pts who
progressed (vs. did not), had lower 1 year mean CD4 (123 vs.
394, P ¼ .02), lower mean CD3 (359 vs. 1147,P ¼ .06), with no
differences in CD8, NK, and CD45RA cells. NRM was associ-
ated with higher mean NK counts at 6 months (499 vs. 188,
P ¼ .01) and with lower mean CD3 at day 90 (184 vs. 557,
P ¼ .07). T-cell recovery occurred most rapidly in MSD
transplants (Figure1), and interestingly, higher CD4CD25 cell
numbers recovered early and most rapidly in the MSD
transplants, which may partly explain a lower incidence of
GVHD in this group. Overall, TCR haplos had a similar pattern
of T-cell recovery and outcomes as 10/10 MUDs (Figure1). No
signiﬁcant differences in T cell subsets found between these
two groups for CD3, CD4, CD8, CD45RA and CD4CD25 at any
time-point. TCD haplos had most impaired T-cell reconsti-
tution and outcomes (Fig. 1), characterized by early NK cell
and delayed CD3, CD4, CD8 recovery. Interestingly, pts
surviving 6-9 months post-transplant recovered CD3, C4,
CD8 cells; however, naïve T-cell recovery was impaired for
more than >1 year post-transplant, suggesting that T cellrecovery comes predominantly from the memory T cell
compartment.
In conclusion, recovery of lymphocyte subsets may
vary widely with the type of transplant, may correlate
with outcomes, and should be further explored post-
transplant.354
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Combined renal and hematopoietic cell transplantation
(HCT) protocols have successfully induced allograft tolerance
despite loss of chimerism in patients; however, the mecha-
nism remains unclear. Using a miniature swine model with
demonstrated clinical relevance, we assessed immune
responses following HCT in ten recipients that lost chime-
rism. All animals received 30 days of cyclosporine (CyA) with
taper until day 45; low-dose total body irradiation (100cGy
TBI) and T cell depletion using a CD3 immunotoxin (pCD3-
IT). Six animals received mobilized donor cells and 4 animals
received unmobilized cells. Control animals received allo-
geneic cells without any immunosuppression. Cellular
responses were assessed bymixed lymphocyte reactivity and
cell mediated lympholysis assays. Donor speciﬁc antibody
was assessed by ﬂow cytometry and complement mediated
cytotoxicity assays.
Following loss of chimerism, anti-donor cellular prolifer-
ative and cytotoxic responses returned without alloantibody.
Alloantibody responses were not induced even after a second
exposure to donor cells intravenously without immunosup-
pression (n¼10) or following donor skin graft rejection
(n¼3). Attempts to further immunize some of these animals
(n¼6) with multiple subcutaneous injections of donor cells
with or without complete Freund's adjuvant also failed to
induce donor speciﬁc antibody. In contrast, control animals
exposed to donor cells without conditioning had sustained
